Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Test Your Knowledge Previous | All Articles This Week | Next
This article originally posted 24 February, 2011 and appeared in  Issue 562, Best of GLP-1, Genetics of Diabetes, SGLT2

TYK #562: Which of the following abnormalities relating to the incretin pathway and renal glucose reabsorption are seen in patients with diabetes?
Advertisement

Which of the following abnormalities relating to the incretin pathway and renal glucose reabsorption are seen in patients with diabetes?

1.    Reduced secretion of GLP-1 and increased expression of SGLT2

2.    Reduced secretion of GLP-1 and reduced expression of SGLT2

3.    Increased secretion of GLP-1 and increased expression of SGLT2

4.    Increased secretion of GLP-1 and reduced expression of SGLT2

Click here for correct answer.

Related Articles

EASD: Weight Loss with SGLT2 Inhibitors but More Infections ADA: First-in-Class Novel Drug Lowers Blood Glucose and Weight AACE: Empagliflozin: Another SGLT2-I on the Rise
Advertisement

 

Bookmark and Share | Print | Category | Home

This article originally posted 24 February, 2011 and appeared in  Issue 562, Best of GLP-1, Genetics of Diabetes, SGLT2

Past five issues: Diabetes Clinical Mastery Series Issue 137 | Issue 677 | SGLT2 Special Edition Issue 2 | Diabetes Clinical Mastery Series Issue 136 | Issue 676 |

 
Diabetes In Control Advertisers
 
Cast Your Vote
What test do you use to screen for prediabetes?

Navigate Diabetes In Control

Cardiovascular CE & CME Clinical Slides Drugs Affecting BG Safety Tools Test Your Knowledge Medications Polls Obesity Case Studies Jobs Interviews GLP-1 Agonist Sheri R. Colberg, PhD SGLT-2

 

Free Weekly Newsletter
Sign up here.

Free CE Available
CE Programs on diabetes

Search Articles On Diabetes In Control